A clinical trial conducted by Cunningham et al. showed that the degree of EGFR expression, either as the percentage of EGFR-positive tumor cells or as the maximal staining intensity per cell, had no relation to the clinical response rate (p = 0.67 and p = 0.84, resp). This evidence concerns the gene EGFR and neoplasm.